Page last updated: 2024-11-05

emylcamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

emylcamate: minor descriptor (66-84); on-line & Index Medicus search CARBAMATES (66-84) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6526
CHEMBL ID2104208
CHEBI ID134769
SCHEMBL ID387718
MeSH IDM0262661

Synonyms (64)

Synonym
striatran
psicoplegil
wln: zvox2&2&1
emylcamat
3-pentanol, carbamate
nsc169882
nsc169917
nuncital
statran
stratran
3-methyl-3-pentanol carbamate
kab 1925
mk-250
kabi-295
emilcamato
jd-91
restetal
methyl diethyl carbinol urethan
78-28-4
diethyl methyl carbinol urethan
1-ethyl-1-methylpropyl carbamate
91 jd
nsc-169882
striatan
tert-hexanol carbamate
nsc-169917
carbamic acid, 1-ethyl-1-methylpropyl ester
emylcamate
kabi-925
3-pentanol, 3-methyl-, carbamate
nsc 169882
carbamic acid, tert-hexyl ester
terc.hexylester kyseliny karbaminove [czech]
brn 1755436
emylcamatum [inn-latin]
einecs 201-101-4
tert-hexyl carbamate
emylcamate [inn:ban]
emilcamato [inn-spanish]
emylcamate (inn)
D07317
CHEBI:134769
3-methylpentan-3-yl carbamate
AKOS006273433
CHEMBL2104208
kabi 925
kcj747d3r4 ,
emylcamatum
unii-kcj747d3r4
terc.hexylester kyseliny karbaminove
emylcamate [who-dd]
emylcamate [inn]
emylcamate [mi]
DTXSID40228645
SCHEMBL387718
SLWGJZPKHAXZQL-UHFFFAOYSA-N
stratan
ethyl2-phenylpropanoate
Z1198155508
DB13572
Q378997
CS-0081492
HY-121340
EN300-212804
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.28 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index56.46 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]